Picture of Petlife Pharmaceuticals logo

PTLF Petlife Pharmaceuticals Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Annual cashflow statement for Petlife Pharmaceuticals, fiscal year end - August 31st, USD millions except per share, conversion factor applied.

2013
August 31st
2014
August 31st
2015
August 31st
2016
August 31st
2017
August 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K/A10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.62-1.51-1.93-3.69-23.3
Non-Cash Items1.161.241.550.74222.5
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.3240.3612.790.453
Change in Prepaid Expenses
Change in Accounts Payable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-0.137-0.267-0.022-0.152-0.319
Capital Expenditures0-0.0010
Purchase of Fixed Assets
Other Investing Cash Flow Items0.10
Sale of Business
Cash from Investing Activities00.1-0.0010
Financing Cash Flow Items0.0070.010
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.1370.1740.0160.1530.372
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-00.007-0.0070.0010.053